Correction to: Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus
- PMID: 37382548
- PMCID: PMC10346389
- DOI: 10.1093/stcltm/szad040
Correction to: Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus
Erratum for
-
Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus.Stem Cells Transl Med. 2023 Jul 14;12(7):431-443. doi: 10.1093/stcltm/szad032. Stem Cells Transl Med. 2023. PMID: 37279956 Free PMC article.